Business
Ukrainian War Veterans Get Better Treatment Than US Military Veterans? – Ukrainian Vets to Get Access to Cannabis
President Zelensky is all for medical marijuana to help Ukrainian war veterans with trama
Ukraine is on the verge of legalizing medical cannabis, primarily relieving war veterans suffering from physical and mental trauma. The UK Telegraph reports that the marijuana bill has passed its initial reading, garnering overwhelming support from 268 out of 344 lawmakers. The legislation awaits a second reading before it reaches President Volodymyr Zelensky for final approval.
The recent development reported by The Telegraph indicates a profound shift in public attitudes towards marijuana following Russia’s invasion of Ukraine. Unlike the year 2021, when a similar bill was quickly rejected, there is now recognition of cannabis as a credible substitute for traditional prescription medications in addressing the physical and mental struggles endured by many soldiers and civilians affected by the war.
Although the numbers for Ukrainian casualties are still unknown, it is assumed that they are less than the 200,000 Russian soldiers thought to have been killed or injured. US intelligence materials leaked in April put the number of casualties among Ukrainian forces between 124,500 and 131,000 by February, including up to 17,500 combat deaths.
Legalizing medical marijuana is supported by the claim that it can effectively treat pain and PTSD symptoms, frequently proving to be a safer alternative to prescribed opiates. According to a World Health Organization research from February, the war may have caused depression or PTSD in about 25% of the Ukrainian populace and 60% of its military. The report also mentioned how trauma unit capacity expansion has taken precedence over mental health care in the nation.
Pushing for Cannabis Legalization in the Parliament
In a speech before the Ukrainian Parliament last month, President Volodymyr Zelensky underlined the significance of adopting the best global practices and effective policies, regardless of how difficult or unconventional they may seem. He aims to protect the Ukrainian population, encompassing all citizens, from the hardships, stress, and trauma inflicted by war.
Specifically, President Zelensky highlighted the need to legalize cannabis-based medicines fairly and regulate those requiring them. He stressed the importance of conducting appropriate scientific research and establishing controlled production within Ukraine. Ukrainska Pravda first covered the report.
The president emphasized that granting access to medical cannabis could offer a therapeutic alternative for citizens who have endured over a year of intense conflict since Russia’s initial invasion of the country in February 2022.
Even during his presidential campaign, Zelensky expressed his backing for legalizing medical cannabis. In 2019, he stated that he believed it would be “normal” to allow people to utilize cannabis “droplets,” potentially referring to marijuana tinctures.
More Actions from Zelensky’s Cabinet
President Zelensky’s Cabinet made a landmark decision that would help Ukraine legalize medical marijuana. In a momentous decision last year, they took a historic step by approving a draft reform legislation now under the Parliament’s consideration. This progressive action can revolutionize healthcare nationwide and open new possibilities for patients seeking complementary therapies.
The new legislation, led by Minister of Healthcare Viktor Liashko, offers enormous hope for people with chronic illnesses, including cancer and post-traumatic stress disorder (PTSD) brought on by the devastation of war. The government wants to foster a climate that will improve patient access to necessary therapies by allowing the controlled circulation of cannabis plants for scientific, industrial, medicinal, and scientific-technical objectives.
Minister Liashko’s profound understanding of the detrimental impact of war on mental health underscores the critical urgency to address any potential aftermath of combat. It is impossible to emphasize the effect of war on people’s psychological health. This is why many people are anticipated to need specialist medical care. As a result, the government is still committed to ensuring patients have access to proven and alternative treatments.
He claimed that the authorities know how bad war is for mental health. Due to these effects, the government is aware of the sizable population needing medical care. There is an immediate urgency to take action.
Opposition From Russia
The proposed change in policy would set Ukraine apart from its longtime foe, Russia, who has vehemently resisted any changes to cannabis laws on the international stage, particularly within the United Nations. The move to make marijuana legal nationwide in Canada has drawn criticism from Russia.
As per a social media post from the official account of the Ministry of Foreign Affairs in Russia, the deputy expressed significant apprehension regarding the legalization efforts in the United States and Canada. The actions of certain European Union Member States considering potential breaches of their drug control obligations are also a cause for concern.
Meanwhile, Congressmen in the US are working harder to persuade the Biden administration to act swiftly to secure the release of Marc Fogel, an American citizen. Fogel is currently incarcerated in Russia, serving a 14-year term for carrying medical marijuana, which he could legally get in Pennsylvania as a registered patient.
According to a press release by Rep. Guy Reschenthaler (R-PA) on Tuesday, Marc Fogel is currently serving a harsh 14-year sentence involving hard labour for possessing medical marijuana, which he used to manage his severe back injury. This situation resembles WNBA player Brittney Griner, who also faced imprisonment in a Russian jail for possessing cannabis oil that she legally obtained as a medical marijuana patient in Arizona.
Rep. Reschenthaler introduced a new bill that would mandate the State Department to explain why individuals like Fogel and other detained Americans have not been officially designated as “wrongfully detained.” This designation is crucial as it would enable escalated diplomatic efforts to secure their release.
In contrast to Fogel’s situation, Brittney Griner was fortunate enough to be recognized by the State Department as wrongfully detained. Consequently, she was released from imprisonment as part of a prisoner swap, which the Biden administration successfully negotiated.
Conclusion
Ukraine’s journey towards legalizing medical cannabis is poised to offer much-needed relief to war veterans and civilians grappling with physical and mental trauma resulting from the conflict. The recent progress in the Ukrainian Parliament, where the marijuana bill received overwhelming support, signals a significant shift in public attitudes towards cannabis.
President Zelensky’s commitment to adopting effective policies, combined with the Cabinet’s landmark decision to pursue cannabis reform, offers hope for improved healthcare and access to alternative therapies for patients in need. While opposition from Russia remains, Ukraine is taking strides towards addressing the well-being of its citizens affected by war-related trauma. The move towards legalization reflects a growing understanding of the potential benefits of medical cannabis in managing pain and PTSD, marking a positive step in addressing the challenges those impacted by the conflict face.
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Marijuana companies suing US attorney general in federal prohibition challenge
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Business
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business1 year ago
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year ago
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year ago
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year ago
Washington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year ago
Marijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year ago
Legal Marijuana Handed A Nothing Burger From NY State
-
Business1 year ago
Can Cannabis Help Seasonal Depression
-
Blogs1 year ago
Cannabis Art Is Flourishing On Etsy